CareDx to Participate in Upcoming Investor Conferences
CareDx (Nasdaq: CDNA), described as The Transplant Company and a leading precision medicine company for transplant patients, will join two investor events in June 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
Jefferies 2026 Global Healthcare Conference at the Marriot Marquis in
New York, NY . Presentation on Wednesday, June 3, 2026, at 5:30pm ET. -
Goldman Sachs 47th Annual Global Healthcare Conference at the Loews Miami Beach Hotel in
Miami Beach, FL.
Fireside chat on Monday, June 8, 2026, at 1:20pm ET.
Live and archived webcasts of the presentations will be available on the “Events and Presentations” section of the CareDx investor relations website at investors.caredx.com.
About CareDx
CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. The Company’s integrated solutions include non‑invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant. CareDx is the leading provider of genomics‑based information for transplant patients. For more information, please visit www.caredx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260520182999/en/
Investor Relations
Caroline Corner
investor@caredx.com
Source: CareDx, Inc.